New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 9, 2014
09:39 EDTWSTAmgen likely plans to use West's SmartDose, says CL King
CL King says a recent investor presentation from Amgen (AMGN) reviewing evolocumab showed a drug administration device that looks identical to West Pharmaceutical's (WST) SmartDose. As such, the firm has a "very high level of confidence" that Amgen will be using West's SmartDose as one of the administration systems for its PCSK9 inhibitor evolocumab. CL King views the development as a "significant positive" for West and reiterates a Strong Buy rating on the stock with a $58 price target. Shares of West Pharmaceutical are up 3% to $45.56 in early trading.
News For WST From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 30, 2014
07:43 EDTWSTWest Pharmaceutical backs FY14 adjusted EPS view of $1.77-$1.82
Subscribe for More Information
07:41 EDTWSTWest Pharmaceutical reports Q3 adjusted EPS 44c, consensus 43c
Reports Q3 revenue $355.9M, consensus $356.08M.
October 21, 2014
08:03 EDTWSTWest Pharmaceutical receives approval for Vial2Bag DC device
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use